A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial

Peer Review reports

Original Submission
11 Feb 2013	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
8 Mar 2013	Reviewed	Reviewer Report - Erik Cobo
22 Mar 2013	Author responded	Author comments - Simon Hyttel-Sorensen
Resubmission - Version 3
22 Mar 2013	Submitted	Manuscript version 3
Publishing
15 Apr 2013	Editorially accepted
1 May 2013	Article published	10.1186/1745-6215-14-120

Back to article page